Susan Ruediger on Pursuing Gene Therapies for CMT
Susan Ruediger, founder and chief mission officer, CMT Research Foundation, discussed the foundation’s mission.
Connecting Patient Advocacy and Industry for Gene Therapy Development
Susan Ruediger, founder and chief mission officer, CMT Research Foundation, discussed the panel discussion she participated in at BIO 2022.
